Lytix Biopharma AS (OSL:LYTIX)
Norway
· Delayed Price · Currency is NOK 9.00
+0.12 (1.35%)
Jul 11, 2025, 4:12 PM CET
Lytix Biopharma AS Market Cap
Lytix Biopharma AS has a market cap or net worth of 614.36 million as of July 11, 2025. Its market cap has increased by 37.60% in one year.
Market Cap
614.36M
Enterprise Value
499.34M
Revenue
608.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
9.00
Market Cap Chart
Since June 14, 2021, Lytix Biopharma AS's market cap has decreased from 720.55M to 614.36M, a decrease of -14.74%. That is a compound annual growth rate of -3.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 614.36M | 53.06% |
| Dec 30, 2024 | 401.38M | 106.12% |
| Dec 29, 2023 | 194.73M | -37.37% |
| Dec 30, 2022 | 310.93M | -41.63% |
| Dec 30, 2021 | 532.66M | -26.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.00B |
| Nordhealth AS | 3.01B |
| Photocure ASA | 1.49B |
| Omda AS | 1.09B |
| Vistin Pharma ASA | 1.06B |
| Gentian Diagnostics ASA | 900.67M |
| Thor Medical ASA | 865.49M |
| ArcticZymes Technologies ASA | 863.11M |